Profiel
Dr. Herwig Gutzeit is Head-Cell Technology & Pharmacology at KINARIS Biomedicals GmbH.
He is on the Board of Directors at Dresden University of Technology.
Dr. Gutzeit was previously employed as a Principal by University of Freiburg.
He received his graduate degree from the University of Oxford and a doctorate degree from the University of Basel.
Actieve functies van Herwig Gutzeit
| Bedrijven | Functie | Begin |
|---|---|---|
Dresden University of Technology
Dresden University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Bestuurslid | - |
Eerdere bekende functies van Herwig Gutzeit
| Bedrijven | Functie | Einde |
|---|---|---|
University of Freiburg
University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
KINARIS Biomedicals GmbH
KINARIS Biomedicals GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures bioactive drugs targeting cellular motor proteins | Oprichter | - |
Opleiding van Herwig Gutzeit
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Freiburg
University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dresden University of Technology
Dresden University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KINARIS Biomedicals GmbH
KINARIS Biomedicals GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures bioactive drugs targeting cellular motor proteins | Health Technology |
















